Palma, Mario https://orcid.org/0009-0007-9456-2096
Chaufan, Milena
Breuer, Cort B. https://orcid.org/0009-0009-2594-3754
Müller, Sebastian https://orcid.org/0000-0002-3423-5364
Sabatier, Marie https://orcid.org/0000-0001-7673-4842
Fraser, Cameron S. https://orcid.org/0000-0002-8180-5913
Szylo, Krystina J. https://orcid.org/0009-0007-0743-4812
Yavari, Mahsa
Carmona, Alanis
Kaur, Mayher
Melo, Luiza Martins Nascentes https://orcid.org/0000-0002-5980-5220
Cansiz, Feyza
Monge-Lorenzo, June https://orcid.org/0009-0007-8943-759X
Flores, Midori
Mishima, Eikan https://orcid.org/0000-0002-3706-2745
Nakamura, Toshitaka
Proneth, Bettina https://orcid.org/0000-0002-4119-9437
Labrado, Marcos https://orcid.org/0009-0008-3981-2651
Liang, Yanshan
Cayting, Nicole
Zheng, Lan
Cañeque, Tatiana https://orcid.org/0000-0002-1110-0643
Colombeau, Ludovic https://orcid.org/0000-0001-5823-2603
Wahida, Adam https://orcid.org/0000-0002-8856-8834
Friedmann Angeli, José Pedro https://orcid.org/0000-0001-7706-1379
Tasdogan, Alpaslan https://orcid.org/0000-0003-2543-852X
Hui, Sheng
Rodriguez, Raphaël https://orcid.org/0000-0001-7668-446X
Conrad, Marcus https://orcid.org/0000-0003-1140-5612
Reticker-Flynn, Nathan E. https://orcid.org/0000-0002-9963-039X
Ubellacker, Jessalyn M. https://orcid.org/0000-0002-7855-9125
Article History
Received: 21 August 2024
Accepted: 6 October 2025
First Online: 5 November 2025
Competing interests
: M. Conrad, B.P., T.N., R.R., S.M., T.C. and L.C. are listed as inventors for some of the compounds described here, and M. Conrad and B.P. are co-founders and shareholders of ROSCUE Therapeutics. The other authors declare no competing interests.